MXCT vs TSLA · rev $38.6M vs P/E 179, rev $94.83B
MaxCyte Inc (MXCT) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported TSLA revenue for 2025-12-31 was $94.83B. Net income was $3.79B. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
MXCT currently screens at market cap $124.3M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the MXCT and TSLA stock pages for the full models.
Not investment advice.